Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
QuintilesIMS
Federal Trade Commission
Cerilliant
Colorcon
Accenture
Daiichi Sankyo
Baxter
Chinese Patent Office

Generated: November 16, 2018

DrugPatentWatch Database Preview

Ziprasidone mesylate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ziprasidone mesylate and what is the scope of ziprasidone mesylate patent protection?

Ziprasidone mesylate is the generic ingredient in one branded drug marketed by Pfizer and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for ziprasidone mesylate. Two suppliers are listed for this compound.

Pharmacology for ziprasidone mesylate
Synonyms for ziprasidone mesylate
122883-93-6,138982-67-9(ClH.H2O),146939-27-7(freebase)
138982-67-9
138982-67-9 (hydrochloride monohydrate)
146939-27-7
146939-27-7 (Parent)
185021-64-1
191Z690
199191-69-0
216X081ORU
2H-Indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-
2H-Indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-, monohydrochloride, monohydrate
2H-Indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-, monomethanesulfonate, trihydrate
2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-
2H-Indol-2-one,5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl_ethyl)-6-chloro-1,3-dihydro-monohydrochloride,monohydrate
3X6SAX83JZ
4169AH
4770-EP2272537A2
4770-EP2272841A1
4770-EP2275420A1
4770-EP2280010A2
4770-EP2298731A1
4770-EP2298776A1
4770-EP2301936A1
4770-EP2308875A1
4770-EP2316836A1
4CH-021473
5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one
5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one
5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indole-2-one
5-(2-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-2-indolinone monohydrochloride, monohydrate
5-(2-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-2-indolinone monomethanesulfonate, trihydrate
5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one
5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one hydrochloride hydrate
5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one methanesulfonate trihydrate
5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one
5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one (Ziprasidone)
5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one(Norastemizole)
5-[2-[4- -1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-onehydrochloride
5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one
5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride monohydrate
5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one Hydrochloride Monohydrate, CP-88059-1
5-[2-[4-(1,2-benzothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydroindol-2-one
5-[2-[4-(1,2-benzothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydroindol-2-one; methanesulfonic acid; trihydrate
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloranyl-1,3-dihydroindol-2-one
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloranyl-1,3-dihydroindol-2-one; methanesulfonic acid; trihydrate
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one hydrate hydrochloride
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one; methanesulfonic acid
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one; methanesulfonic acid; trihydrate
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;hydrate;hydrochloride
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-indolin-2-one
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-indolin-2-one hydrate hydrochloride
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-indolin-2-one; methanesulfonic acid
5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-2,3-dihydro-1H-indol-2-one
6-chloro-5-[2-[4-(7-thia-8-azabicyclo[4.3.0]nona-1,3,5,8-tetraen-9-yl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one
6-chloro-5-[2-[4-(9-thia-8-azabicyclo[4.3.0]nona-1,3,5,7-tetraen-7-yl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one; methanesulfonic acid
6UKA5VEJ6X
883Z936
982Z679
A808568
A814073
AB00639925_05
AB00639925_06
AB00639925-02
AB00639925-04
AC-23355
AC-23360
AC1L1U24
AC1L1U27
AC1L4BMU
AC1LCVEM
AC1Q3ESV
ACM199191690
AJ-23401
AK-75766
AK390026
AKOS015900335
AKOS015900383
AKOS015961662
AKOS027379883
AM90310
Ambap122883-93-6
AN-16930
AN-30104
AN-9382
ANW-58715
API0004647
API0004648
AS-16359
BC207663
BC643069
BDBM50048803
BIDD:GT0042
C-35605
C07568
C21H21ClN4OS
C21H21ClN4OS.CH4O3S
C21H21ClN4OS.HCl
C21H21ClN4OS.HCl[H2O]
CAS-146939-27-7
CCG-213218
CCG-222329
CHEBI:10119
CHEBI:32314
CHEBI:53757
CHEMBL1200997
CHEMBL1375743
CHEMBL708
CP 88-059-01
CP 88,059-1
CP 88059
CP 88059-01
CP 88059-1
CP 88059;CP-88059;CP88059
CP-88, 059-27
CP-88,059
CP-88,059-01
CP-88,059-1
CP-88,059-27
CP-88059
CP-88059-01
CP-88059-1
CP-88059-27
CP-880591
CP-8805927
CPD000466328
CS-1071
CS-1198
CTK0H9267
CTK8B7827
CZ0013
CZ0014
CZ0015
D01939
D02100
D08687
D0E0NJ
D0R1JV
DB00246
DSSTox_CID_3753
DSSTox_GSID_23753
DSSTox_RID_77186
DTXSID00160855
DTXSID4023753
FT-0600387
FT-0654208
FT-0655916
Geodon
Geodon (TN)
Geodon Hydrochloride Hydrate
Geodon Oral
GP6084
GTPL59
HE230994
HE323107
HMS3264B21
HSDB 7745
HY-14542
HY-17407
I14-0761
I14-0766
J-007206
KB-243244
L000659
LOQSYPGSAZUDJZ-UHFFFAOYSA-N
LP01025
LS-173039
LS-183398
LS-83744
ME-2112
MFCD00921885
MLS000759435
MolPort-003-850-885
MolPort-005-934-812
MVWVFYHBGMAFLY-UHFFFAOYSA-N
NCGC00186050-01
NCGC00261710-01
NCGC00263539-01
NCGC00263539-03
NSC-760351
NSC760351
Pharmakon1600-01503850
RTR-031719
SAM001246607
SC-22049
SCHEMBL122875
SCHEMBL28028
SCHEMBL957247
SMR000466328
ST24044165
ST51053939
SYN3019
TC-5280
TL8000889
Tox21_112194
Tox21_112194_1
Tox21_113525
Tox21_501025
TR-031719
TRA0084802
UNII-216X081ORU
UNII-3X6SAX83JZ
UNII-6UKA5VEJ6X
UNII-VCY3F61S5R
VCY3F61S5R
VU0286234-2
W-5149
zaprasidone
ZCBZSCBNOOIHFP-UHFFFAOYSA-N
Zeldox
Zeldox (TN)
ZINC538550
Zipradon
Zipradon (TN)
ziprasidona
Ziprasidone
Ziprasidone (hydrochloride monohydrate)
Ziprasidone (INN)
Ziprasidone [INN:BAN]
Ziprasidone for system suitability 1, European Pharmacopoeia (EP) Reference Standard
Ziprasidone for system suitability 2, European Pharmacopoeia (EP) Reference Standard
Ziprasidone HCl hydrate
Ziprasidone HCl monohydrate
Ziprasidone hydrochloride
Ziprasidone hydrochloride (USAN)
Ziprasidone hydrochloride [USAN:USP]
Ziprasidone hydrochloride [USAN]
Ziprasidone hydrochloride hydrate (JAN)
Ziprasidone hydrochloride monohydrate
Ziprasidone Hydrochloride Monohydrate 1.0 mg/ml in Methanol (as anhydrous free base)
Ziprasidone hydrochloride monohydrate, >=98% (HPLC), solid
Ziprasidone hydrochloride monohydrate, European Pharmacopoeia (EP) Reference Standard
ziprasidone hydrochloride, monohydrate
Ziprasidone hydrochloride, United States Pharmacopeia (USP) Reference Standard
Ziprasidone mesilate
Ziprasidone mesylate (USAN)
Ziprasidone mesylate [USAN]
Ziprasidone mesylate hydrate
Ziprasidone mesylate trihydrate
Ziprasidone solution, 1.0 mg/mL in 1,2-dimethoxyethane, ampule of 1 mL, certified reference material
ziprasidonum
ziprazidone
ZLA0004
zlchem 4

US Patents and Regulatory Information for ziprasidone mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer GEODON ziprasidone mesylate INJECTABLE;INTRAMUSCULAR 020919-001 Jun 21, 2002 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for ziprasidone mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer GEODON ziprasidone mesylate INJECTABLE;INTRAMUSCULAR 020919-001 Jun 21, 2002 ➤ Sign Up ➤ Sign Up
Pfizer GEODON ziprasidone mesylate INJECTABLE;INTRAMUSCULAR 020919-001 Jun 21, 2002 ➤ Sign Up ➤ Sign Up
Pfizer GEODON ziprasidone mesylate INJECTABLE;INTRAMUSCULAR 020919-001 Jun 21, 2002 ➤ Sign Up ➤ Sign Up
Pfizer GEODON ziprasidone mesylate INJECTABLE;INTRAMUSCULAR 020919-001 Jun 21, 2002 ➤ Sign Up ➤ Sign Up
Pfizer GEODON ziprasidone mesylate INJECTABLE;INTRAMUSCULAR 020919-001 Jun 21, 2002 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
QuintilesIMS
Federal Trade Commission
Cerilliant
Colorcon
Accenture
Daiichi Sankyo
Baxter
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.